Brief: Enorama Pharma Q4 Oper Loss Widens To SEK 7.0 Million
20/02/2020 07:41
Feb 20 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q4 NET SALES SEK 0.7 MILLION VERSUS SEK 1.1 MILLION YEAR
AGO
* Q4 OPER LOSS SEK 7.0 MILLION VERSUS LOSS SEK 6.1 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr8wSDgx
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO